[1]
Zhu, E., Oh, J., Dambkowski, C. and Shaheen, H. 2024. APG777, a High-Affinity Humanized IgG1 Monoclonal Antibody Targeting IL-13, Demonstrates Prolonged Half-Life in Non-Human Primates. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s315. DOI:https://doi.org/10.25251/skin.8.supp.315.